Table III.

Meta-analysis of the association between the VEGF +936C/T polymorphism and gastric cancer risk.

Comparisons	OR	95% CI	P-value	Heterogeneity		Effects model
				I2	P-value
T vs. C	1.08	0.90–1.30	0.42	64%	0.007	Random
Caucasian	1.18	0.93–1.51	0.17	0%	0.650
Asian	1.05	0.82–1.34	0.72	76%	0.002
T/T+C/T vs. C/C	1.08	0.87–1.34	0.49	63%	0.008	Random
Caucasian	1.27	0.94–1.72	0.12	0%	0.730
Asian	1.02	0.77–1.35	0.88	75%	0.003
T/T vs. C/C+C/T	1.14	0.85–1.53	0.37	32%	0.170	Fixed
Caucasian	1.07	0.68–1.66	0.78	0%	0.810
Asian	1.21	0.82–1.79	0.34	59%	0.050
T/T vs. C/C	1.18	0.87–1.59	0.28	41%	0.100	Fixed
Caucasian	1.15	0.73–1.82	0.55	0%	0.660
Asian	1.20	0.81–1.77	0.37	64%	0.030
T/T vs. C/T	1.11	0.79–1.56	0.56	27%	0.220	Fixed
Caucasian	0.82	0.43–1.57	0.55	0%	0.590
Asian	1.25	0.83–1.87	0.28	47%	0.110

OR, odds ratio; 95% CI, 95% confidence interval.